MPW Repeat Winners: How Namita Thapar steered Emcure Pharma through a massively successful IPO
Thapar, a judge on Shark Tank India, is clear that Emcure is poised for growth.
- Nov 12, 2024,
- Updated Nov 13, 2024 12:37 PM IST
It has been quite a year for Namita Thapar. “All the hard work we put in for Emcure’s IPO (in July) was super successful. Being a part of the senior team and leading the roadshows was exciting, exhausting and a great learning experience,” she says.
Life after going public will not be the same, but a confident Thapar thinks it is great for the Emcure brand and “building trust and pride for all our stakeholders”.
Thapar, a judge on Shark Tank India, is clear that Emcure is poised for growth. “It will be driven primarily by our science-led portfolio, a competent management team, a great mix of professionals and family members,” she says, adding that she is excited about Emcure’s foray into consumer health, with a focus on women’s health.
It has been quite a year for Namita Thapar. “All the hard work we put in for Emcure’s IPO (in July) was super successful. Being a part of the senior team and leading the roadshows was exciting, exhausting and a great learning experience,” she says.
Life after going public will not be the same, but a confident Thapar thinks it is great for the Emcure brand and “building trust and pride for all our stakeholders”.
Thapar, a judge on Shark Tank India, is clear that Emcure is poised for growth. “It will be driven primarily by our science-led portfolio, a competent management team, a great mix of professionals and family members,” she says, adding that she is excited about Emcure’s foray into consumer health, with a focus on women’s health.